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Abstract
Background: Alpha-synuclein (a-Syn) is a small neuronal protein that has been found to be expressed throughout the brain.
It has been shown that a-Syn regulates the homeostasis of monoamine neurotransmitters and is involved in various
degenerative and affective disorders. There is indication that a-Syn may regulate expression of the brain-derived
neurotropic factor (BDNF) which plays an important role in the mood disorders.
Methodology/Principal Findings: The study aimed to analyze the mRNA levels of Snca and Bdnf genes in the ventral
tegmental area (VTA) and raphe nuclei of the midbrain in male mice that had each won or defeated 20 encounters (20-time
winners and 20-time losers, respectively) in daily agonistic interactions. Groups of animals that had the same winning and
losing track record followed by a no-fight period for 14 days (no-fighting winners and no-fighting losers) were also studied.
Snca mRNA levels were increased in the raphe nuclei in the 20-time losers and in the VTA of the 20-time winners. After no-
fight period Snca mRNA levels decreased in both groups. Snca mRNA levels were similar to the control level in the VTA of
the 20-time losers and in the raphe nuclei of the 20-time winners. However Snca gene expression increased in these areas in
the no-fighting winners and no-fighting losers in comparison with respective mRNA levels in animals before no-fight period.
Bdnf mRNA levels increased in VTA of 20-time winners. Significant positive correlations were found between the mRNA
levels of Snca and Bdnf genes in the raphe nuclei.
Conclusions/Significance: Social experience affects Snca gene expression depending on brain areas and functional activity
of monoaminergic systems in chronically victorious or defeated mice. These findings may be useful for understanding the
mechanisms of forming different alpha-synucleinopathies.
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Introduction
Alpha-synuclein (a-Syn) is a small neuronal protein localized in
the presynaptic compartment of neurons that has been found to be
expressed throughout the brain [1,2]. It has been shown that a-
Syn regulates the homeostasis of monoamine neurotransmitters,
through its trafficking, and regulation of the cell surface
expression and, thereby, the activity of dopamine, serotonin and
norepinephrine transporters [3–5]. a-Syn is involved in various
degenerative disorders such as Parkinson’s disease, dementia with
Lewy bodies [review 1, 3, 6, 7], which are recognized as alpha-
synucleinopathies. It is suggested that a-Syn may also play a
pathophysiological role in depressive symptoms [8,9].
Previous data have revealed that long positive or negative
fighting experience in daily agonistic interactions in male mice is
accompanied by different changes in brain neurochemical
activities. It has been experimentally demonstrated that repeated
aggression which is accompanied by victories, leads to total
activation of brain dopaminergic systems. This activation was
detected in the winners as elevated DOPAC (3,4-dihydroxyphe-
nyleacetic acid) levels or/and increased DOPAC/DA (dopamine)
ratios in different brain areas [10,11]. Enhanced expression of the
Th, Dat1 and Snca genes [12,13], which are associated with brain
dopaminergic systems was shown in the ventral tegmental area
(VTA) of the winners. Reduced activity of brain serotonergic
system was suggested to be developed under repeated experience
of aggression as has been shown by decreased tryptophan
hydroxylase activity in some brain areas [14–16]. Daily social
defeats are accompanied by activation of serotonergic system as
shown by changes of serotonin and 5-hydroxyindoleacetic acid
levels in different brain areas of the losers [10,17] and enhanced
expression of Sert and MaoA genes in the raphe nuclei of the
midbrain [18]. Reduced activity of brain dopaminergic systems
was supposed in defeated animals [17].
The paper aimed to study the possible changes of Snca gene
expression in animals with different brain monoaminergic activity.
We focused on the VTA containing the cell bodies of mesolimbic
dopaminergic neurons, because mesolimbic dopaminergic projec-
tions from the VTA play an important role in the mediation of
rewarding processes [19] which is supposed to accompany positive
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bodies of serotonergic neurons whose projections are involved into
regulation of stress, depression, anxiety and in many kinds of social
behaviors was also studied.
The brain-derived neurotrophic factor (BDNF) is associated
with many psychiatric disorders such as depression and anxiety
[22,23] by participating in differentiation, growth and mainte-
nance of neuronal cells. Differently directed changes BDNF and a-
Syn were revealed in the pathogenesis of Parkinson’s disease
affecting dopaminergic systems [7;24]. Moreover there was
indication that overexpression of a-syn may decrease BDNF
expression [25]. It was supposed that Bdnf gene together with Snca
gene in the VTA and raphe nuclei of midbrain may be involved in
the consequences of repeated agonistic interactions. Expression of
Bdnf gene was also studied in the VTA and raphe nuclei of
midbrain in the mice before and after period of repeated agonistic
interactions.
Materials and Methods
Animals and housing
Adult male mice of the C57BL/6J strain from a stock
maintained in the Animal Facility of the Institute of Cytology
and Genetics, SD RAS, (Novosibirsk, Russia) were used. The
animals were housed under standard conditions (12:12 h light/
dark regime, switch-on at 8.00 a.m.; food (pellets) and water
available ad libitum). Mice were weaned at one month of age and
housed in groups of 8–10 in plastic cages (36623612 cm).
Experiments were performed on mice 10–12 weeks of age.
Ethics Statement
All procedures were in compliance with the European
Communities Council Directive of November 24, 1986 (86/
609/EEC). This study was approved by Scientific Council N 9 of
the Institute of Cytology and Genetics SD RAS of March, 24,
2010, N 613.
Chronic agonistic interactions (winners and losers)
Aggressive or submissive behaviors in male mice were induced
using the sensory contact model [26]. Pairs of weight-matched
animals were each placed in a steel cage (28614610 cm) bisected
by a perforated transparent partition allowing the animals to see,
hear and smell each other, but preventing physical contact. The
animals were left undisturbed for three days to adapt to new
housing conditions and sensory contact before they were exposed
to encounters. In the second half of the light period, the lid was
replaced by a transparent one and five minutes later the partition
was removed for 10 minutes to encourage agonistic interactions.
The superiority of one of the mice was firmly established within
two or three encounters (three days) with the same opponent. The
superior mouse would be attacking, biting and chasing another,
who would be displaying only defensive behavior (sideways
postures, upright postures, withdrawal, lying on the back or
freezing). As a rule, in our experiments, aggressive confrontations
between males are discontinued by lowering the partition if the
aggression has lasted more then 3 min or less. Each defeated
mouse (loser) was exposed to the same winner for three days, while
afterwards each loser was placed, once a day after the fight, in an
unfamiliar cage with an unfamiliar winner behind the partition.
Each victorious mouse (winner) remained in its original cage. This
procedure was performed for 20 days and yielded an equal
number of winners and losers.
Five groups of animals were used. (1) 20-time winners: a group
of mice that had each won 20 encounters in succession (2) No-
fighting winners: a group of 20-time winners who were allowed to
live for 14 days after the last encounter without agonistic
interactions; (3) 20--time losers: a group of mice that had each
defeated 20 encounters; (4) No-fighting losers: a group of 20-time
losers who were allowed to live for 14 days after the last encounter
without agonistic interactions. During the no-fight period animals
shared a cage with a partner (losers or winners); the partition
between their compartments being down at all times, to prevent
encounters. (5) Controls: the mice that had been housed
individually for five days. The rationale for this choice is that it
gives the best trade-off between group housing and social isolation:
five days is sufficient for group housing to no longer be a factor
and insufficient for social isolation to become a factor. Special
investigations confirmed strong rationality of this control in the
sensory contact model [27]. Each experimental group contained
7–13 animals.
To measure mRNA levels in the brain areas, all the mice were
decapitated simultaneously: 20-time winners and 20-time losers,
24 hours after the last agonistic interaction; no-fighting winners
and no-fighting losers, immediately after 14-day no-fight period;
and the controls, on day 6 of individual housing. The mouse brains
were removed and chilled rapidly on ice. The VTA and raphe
nuclei were dissected according to the Mouse Brain Atlas [28].
Obtained tissue was rapidly frozen in liquid nitrogen and stored at
270uC until used.
Total RNA extraction and reverse transcription. Total
RNA was extracted from each individual brain tissue sample using
the Chomczynski and Sacchi method [29] with modifications.
Total RNA was quantified by measuring the absorbance at
260 nm. The integrity of total RNA was assessed by agarose gel
electrophoresis. 1 mg of total RNA was used for cDNA synthesis by
MoMLV reverse transcriptase (Biosan, Novosibirsk, Russia).
Real-time quantitative PCR
Amplification was performed using an iQ5 iCycler (Bio-Rad,
Hercules, CA, USA). Bdnf, b-actin (Actb), and cyclophilin (Cphn)
mRNA levels were quantified by TaqMan real-time PCR. PCR
was performed in a total volume of 25 ml containing an aliquot of
the RT mixture, dNTPs, the appropriate concentrations of sense
and anti-sense primers, a TaqMan probe, PCR buffer, and hot-
start Taq DNA polymerase (Biosan, Novosibirsk, Russia).
Amplification was run for 2 min at 96uC, followed by 37 cycles
of 15 s at 96uC, 45 s at 61uC. Fluorescence was monitored for 10 s
after the last cycle.
Snca mRNA levels were quantified by Sybr Green I real-time
PCR in a total volume of 25 ml containing an aliquot of the RT
mixture, dNTPs, the appropriate concentrations of the sense and
anti-sense primers, Sybr Green I (Invitrogen), PCR buffer, and
hot-start Taq DNA polymerase. Amplification was run for 3 min
at 95uC, followed by 40 cycles of 10 s at 92uC, 6 s at 60uC, 6 s at
72uC and 10 s at 85uC. Fluorescence was monitored for 10 s after
the last cycle. To check for the presence of non-specific PCR
products or primer-dimers, a melting curve analysis was
performed after the final PCR cycle.
Amplification efficiencies were calculated a relative standard
curve derived from fourfold serial dilutions of pooled cDNA. In all
cases, the amplification efficiency was higher than 85%. Each
sample was PCR-amplified twice. RT-PCR results were quantified
using the relative standard curve method. The level of expression
of each gene was normalized to the mean level of expression of the
Actb and Cphn genes. The oligonucleotide primers and probes were
designed using Beacon Designer 5.0 (PREMIER Biosoft Interna-
tional, USA). The PCR primer and probe sequences are shown in
Table 1.
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Two-way ANOVA of ranked data was used to reveal effect of
factors ‘‘social status’’ (20-time winners and 20-time losers) and
‘‘no-fight period’’ and its interactions. Statistical analysis of data
was also performed using the Kruskal-Wallis one-way analysis of
variance (ANOVA) with factor ‘‘groups’’ in consideration – the
control, 20-time winners, 20-time losers, no-fighting winners and
no-fighting losers. A post-hoc pair-wise comparison of the groups
was made with the Mann-Whitney U test. Correlations were
assessed using Spearman’s rank correlation coefficient. We
searched for correlations between the Bdnf and Snca mRNA
levels in each experimental group separately and in combination.
The statistical significance was set at P#0.05; the trend level was
set at 0.05,P,0.1.
Results
For the Snca mRNA levels, two-way ANOVA for ranked data
reports a significant interaction for ‘‘social status’’ and ‘‘no-fight
period’’ factors in the raphe nuclei (F(1,47)=15.57, p,0.001) and
in the VTA (F(1,33)=15.87, p,0.001). For the Bdnf mRNA levels
no significant interactions were found between social status and
no-fight period effects in the raphe nuclei (F(1,47)=1.02, NS) and
in the VTA (F(1,31)=0.44, NS).
Kruskal-Wallis analysis revealed a significant influence of the
factor ‘‘groups’’ for the Snca mRNA level in the VTA (H (4,
N=44)=14.41, p,0.01) and in the raphe nuclei (H (4,
N=64)=13.69, p,0.01) as well as for the Bdnf mRNA level in
the raphe nuclei (H (4, N=64)=10.58, p,0.05). There was no
significant influence of the factor ‘‘groups’’ on the Bdnf mRNA
level in the VTA (H (4, N=42)=2.96, NS).
Based on the Mann-Whitney U test (Figure 1), in the VTA, the
20-time winners and no-fighting losers had increased Snca mRNA
levels as compared to the control (U=16; p,0.05 and U=7;
p,0.05, respectively). Groups of the 20-time winners and 20-time
losers as well as groups of the no-fighting winners and no-fighting
losers differed significantly (U=31; p,0.05 and U=8; p,0.05,
respectively). No-fighting losers had increased Snca mRNA levels
as compared to the 20-time losers before no-fight period (U=2;
p,0.001).
In the raphe nuclei, the no-fighting winners had increased Snca
mRNA levels as compared to the 20-time winners (U=41;
p,0.05). No-fighting losers had decreased Snca mRNA levels as
compared to the levels in the 20-time losers (U=30; p,0.01).
There were significant differences in the Snca mRNA levels
between the 20-time winners and 20-time losers (U=38; p,0.05)
as well as the no-fighting winners and no-fighting losers (U=29;
p,0.01). Differences in mRNA levels between the control and no-
fighting winners and between the control and 20-time losers were
not definitely significant, but strongly suggestive (p=0.086 and
p=0.061, respectively). The 20-time winners had increased Bdnf
mRNA level as compared to the control (U=22; p,0.01). Other
pair comparisons failed to reach significance.
Based on Spearman’s rank correlation coefficient, there were
significant positive correlations in the raphe nuclei between the
mRNA levels of Bdnf and Snca genes in the groups of the 20-time
winners and no-fighting winners (R=0.643, p,0.05 and
R=0.734, p,0.01, respectively); in the group of the 20-time
losers (R=0.560, p,0.05); and in all groups in combination using
pooled data from all the groups (R=0.397, p,0.001). There was
one significant positive correlation in the VTA between the
mRNA levels of Bdnf and Snca genes in the control (R=0.893,
p,0.01).
Discussion
It has been shown that long positive fighting experience in daily
agonistic interactions is accompanied by activation of brain
dopaminergic systems and reduced serotonergic activity in male
mice [16]. Chronic social defeat stress is accompanied by
activation of the brain serotonergic system and, presumably,
decreased dopaminergic activities [17]. Our neurochemical
observations in the aggressive mice (winners) are in agreement
with other studies in animals and humans [30–32].
Two-way ANOVA for the Snca mRNA levels in the raphe
nuclei and VTA showed significant interaction effects between
‘‘social status’’ and ‘‘no-fight period’’ factors. This means that
expression of the Snca gene in brain areas changes differently in
animals with positive or negative fighting experience and that the
changed monoaminergic activity influences gene expression
during no-fight period. Increased mRNA levels of the Snca gene
were found in the 20-time winners’ VTA and in the 20-time losers’
raphe nuclei in comparison with respective level in opposite social
group. On the contrary, decreased Snca mRNA level was found in
no-fighting winners’ VTA and in the no-fighting losers’ raphe
nuclei in similar comparisons.
Our data suggests that: the changes in Snca gene expression are
a consequence of the functional state of the brain dopaminergic
and serotonergic systems. Enhanced expression of the Snca gene
due to repeated aggression or defeats is associated with activation
of the leading monoaminergic systems: mesolimbic dopaminergic
system in the VTA of the 20-time winners and serotonergic system
in the raphe nuclei of the 20-time losers. After no-fight period
increased Snca gene expression in both areas reverts to the control
level. On the contrary, when reduced activity of dopaminergic
systems in the 20-time losers’ VTA or serotonergic system in the
20-time winners’ raphe nuclei is suggested, no changes in Snca
gene expression were found under repeated agonistic interactions.
After no-fight period the Snca mRNA levels are increased in these
areas. Since similar changes in Snca gene expression were found in
different brain areas, Snca may act as a common regulator of
monoaminergic activity as shown earlier [3,4].
Our data provide evidence that the Snca gene may be part of a
feedback mechanism in regulation of neurotransmitters’ metabo-
lism. It has been shown, that the presynaptic protein a-Syn
negatively modulates DAT and SERT activity [6,33]. Increase of
the Snca mRNA levels may be a response to the increase of Dat1
mRNA level in the winners’ VTA and Sert mRNA level in the
Table 1. Primers and probe sequences.
Genes Primer and probe sequences
Bdnf Sense 59-ACTATGGTTATTTCATACTTCGGTT-39
anti-sense 59-CCATTCACGCTCTCCAGA-39
Probe 59-FAM-CGTCCACGGACAAGGCAACTT-BHQ1-39
Snca Sense 59-TGACAGCAGTCGCTCAGA-39
anti-sense 59-CATGTCTTCCAGGATTCCTTC-39
Cphn Sense 59-GAGAACTTCATCCTAAAGCATACAG-39
anti-sense 59-TCACCTTCCCAAAGACCA-39
Probe 59- TAMRA -CGTTGCCATCCAGCCATTCAG-BHQ2-39
Actb Sense 59- TCTTTGCAGCTCCTTCGTT -39
anti-sense 59-CGATGGAGGGGAATACAG-39
Probe 59- ROX-CACACCCGCCACCAGTTCGC-BHQ2-39
doi:10.1371/journal.pone.0014089.t001
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mRNA level of Snca gene reverts to the control level. Noteworthy,
over-expression of the Snca gene in the VTA was found in the 20-
time winners and in the no-fighting losers in comparison with the
control. Some authors suggest [6] that over-expression of the Snca
gene may block its neuroprotective properties. Our observations
are in agreement with those of Mash and co-workers [34] who
have demonstrated over-expression of Snca gene in the VTA in
chronic cocaine abusers, which was shown to activate the brain
dopaminergic systems [35]. Increased mRNA level of Snca gene
was also found after amphetamine injections [36].
Two-way ANOVA for Bdnf mRNA levels did not reveal
significant interaction effects for ‘‘social status’’ and ‘‘no-fight
period’’ in both areas. However, the expression of some genes may
increase rapidly and decrease abruptly, while that of other genes
changes more gradually [37]. As Miczek and the co-workers report
[38], continuous subordination stress leads to significantly
decreased levels of BDNF protein in the VTA compared to
control levels, whereas intermittent social defeat stress episodes
result in increased BDNF protein levels. Thus, the lack of changes
in Bdnf mRNA levels in the 20-time losers could be explained by
transient (dynamic) changes of gene expression shown, for
example, for the genes of kappa-opioid receptors [39,40], mu-
opioid receptors [41,42], and proenkephalin [43] in some brain
areas in response to exposure to the experimental settings. If this
explanation is correct, we cannot completely exclude the
involvement of Bdnf in the mechanisms underlying repeated
aggression or defeats. This expectation is supported by increased
Bdnf mRNA level in the 20-time winners’ raphe nuclei in
comparison with the controls and by the presence of positive
functional correlations between the Bdnf and Snca mRNA levels in
the raphe nuclei. These data suggest that BDNF may play an
important role in regulation of serotonergic activity. In the VTA,
positive correlation between the Bdnf and Snca mRNA levels was
found only in the control mice. However, the intrinsic molecular
mechanisms responsible for the functional association have yet to
be revealed. The reason for this correlative relationship might be
the common molecular mechanisms of transcriptional regulation
of these genes.
Thus, chronic manifestation of aggression, which leads to
activation of dopaminergic metabolism in the brain areas,
enhances in the VTA the expression of the Th, Dat1 and Snca
Figure 1. The normalized Snca and Bdnf mRNA levels in the VTA and raphe nuclei of midbrain of the controls (white columns), 20-
time winners and 20-time losers (grey columns) and no-fighting winners and no-fighting losers (black columns). * p,0.05; ** p,0.01;
*** p,0.001; # - 0.05,p,0.1 comparisons between respective groups.
doi:10.1371/journal.pone.0014089.g001
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Mesolimbic dopaminergic projections from the VTA play an
important role in the mediation of rewarding processes. It is
therefore possible that the observed changes of the Snca genes
expression display the dopaminergic mechanisms from experienc-
ing positive emotions over social victories in the winners. Because
social defeats lead to the activation of the serotonergic system
[17,44], the changes in the Snca mRNA levels in the losers’ raphe
nuclei lend support to the involvement of a-Syn in the
consequence of chronic negative emotions.
It has been shown earlier that long positive fighting history leads
to development of behavioral psychopathology, which includes the
demonstration of abnormal aggression, malignancy, strong
hostility, pronounced anxiety, disturbances in social recognition,
hyperactivity, stereotypic and hyperkinetic reactions [16]. Male
mice with long defeat history developed a psychoemotional
disorder similar to anxious depression in accordance with
symptomatics, etiology factors, brain neurochemical changes and
sensitivity to antidepressants and anxiolytics similar to those in
depressive persons [17,44]. It may be concluded that Snca gene
may be involved in pathogenesis of these disorders. In this context
our assumption is in agreement with earlier reports [8,45,46]
which have demonstrated that the ability of a-Syn to modulate
SERT and DAT functions may be of pathological significance,
particularly with regard to psychiatric disorders such as depres-
sion, suicide, and impulsive violence.
It must be noted that the activities of all neurotransmitter
systems may be dynamically changed as for metabolism, receptors
and enzyme activities in male mice in response to chronic
activation or inhibition of neurotransmitter’ systems depending on
social status and/or duration of repeated agonistic interactions
[16,17]. Our behavioral approach makes it possible to track
changes in gene functioning during development of behavioral
pathologies [47], and to study the transcriptional state of a set of
genes, which may be involved in the brain pathogenesis.
Author Contributions
Conceived and designed the experiments: NNK. Performed the experi-
ments: NNB UAB MLF. Analyzed the data: NNK NNB UAB MLF.
Contributed reagents/materials/analysis tools: UAB MLF. Wrote the
paper: NNK NNB MLF.
References
1. George JM (2002) The synucleins. Genome Biol 3(1): REVIEWS3002.
2. Totterdell S, Hanger D, Meredith GE (2004) The ultrastructural distribution of
alpha-synuclein-like protein in normal mouse brain. Brain Res 1004(1–2):
61–72.
3. Wersinger C, Rusnak M, Sidhu A (2006) Modulation of the trafficking of the
human serotonin transporter by human alpha-synuclein. Eur J Neurosci 24(1):
55–64.
4. Wersinger C, Jeannotte A, Sidhu A (2006) Attenuation of the norepinephrine
transporter activity and trafficking via interactions with alpha-synuclein.
Eur J Neurosci 24(11): 3141–3152.
5. Yavich L, Tanila H, Vepsalainen S, Jakala P (2004) Role of alpha-synuclein in
presynaptic dopamine recruitment. J Neurosci 24: 11165–11170.
6. Sidhu A, Wersinger C, Moussa CE, Vernier P (2004) The role of alpha-
synuclein in both neuroprotection and neurodegeneration. Ann NY Acad Sci
1035: 250–270.
7. Kao AW, Racine CA, Quitania LC, Kramer JH, Christine CW, et al. (2009)
Cognitive and neuropsychiatric profile of the synucleinopathies: Parkinson
disease, dementia with lewy bodies, and multiple system atrophy. Alzheimer Dis
Assoc Disord 23(4): 365–370.
8. Frieling H, Gozner A, Ro ¨mer KD, Wilhelm J, Hillemacher T, et al. (2008)
Alpha-synuclein mRNA levels correspond to beck depression inventory scores in
females with eating disorders. Neuropsychobiology 58(1): 48–52.
9. Jeannotte AM, McCarthy JG, Redei EE, Sidhu A (2009) Desipramine
modulation of alpha-, gamma-synuclein, and the norepinephrine transporter
in an animal model of depression. Neuropsychopharmacology 34(4): 987–998.
10. Kudriavtseva NN, Bakshtanovskaia IV (1991) The neurochemical control of
aggression and submission. Zh Vyssh Nerv Deiat Im IP Pavlova 41: 459–466.
11. Devoino LV, Idova GV, Al’perina EL, Cheido MA (1998) The neurochemical
set of the brain–an extra-immune mechanism of psychoneuroimmunomodula-
tion. Vestn Ross Akad Med Nauk 9: 19–24.
12. Filipenko ML, Alekseyenko OV, Beilina AG, Kamynina TP, Kudryavtseva NN
(2001) Increase of tyrosine hydroxylase and dopamine transporter mRNA levels
in ventral tegmental area of male mice under influence of repeated aggression
experience. Brain Res Mol Brain Res 96: 77–81.
13. Bondar NP, Boyarskikh UA, Kovalenko IL, Filipenko ML, Kudryavtseva NN
(2009) Molecular implications of repeated aggression: Th, Dat1, Snca and Bdnf
gene expression in the VTA of victorious male mice. PLoS ONE 4(1): e4190.
14. Amstislavskaya TG, Kudryavtseva NN (1997) Effect of repeated experience of
victory and defeat in daily agonistic confrontations on brain tryptophan
hydroxylase activity. FEBS Lett 406: 106–108.
15. Kulikov AV, Kozlachkova EY, Kudryavtseva NN, Popova NK (1995)
Correlation between tryptophan hydroxylase activity in the brain and
predisposition to pinch-induced catalepsy in mice. Pharmacol Biochem Behav
50:3: 431–435.
16. Kudryavtseva NN (2006) Psychopathology of repeated aggression: a neurobi-
ological aspect. In Morgan JP, ed. Perspectives on the Psychology of Aggression
NOVA Science Publishers Inc. pp 35–64.
17. Avgustinovich DF, Alekseyenko OV, Bakshtanovskaya IV, Koryakina LA,
Lipina TV, et al. (2004) Dynamic changes of brain serotonergic and
dopaminergic activities during development of anxious depression: Experimental
Study. Usp Fiziol Nauk 35(4), 19–40. Russian.
18. Filipenko ML, Beilina AG, Alekseyenko OV, Dolgov VV, Kudryavtseva NN
(2002) Increase in expression of brain serotonin transporter and monoamine
oxidase a genes induced by repeated experience of social defeats in male mice.
Biochemistry 67: 451–455.
19. Cooper SJ (1991) Interaction between endogenous opioids and dopamine:
Implications for reward and aversion. In: Willner P& Scheel-Kruger J, eds. The
mesolimbic dopamine system: from motivation to action. London: John Wiley
Sons Ltd. pp 331–366.
20. Fish EW, De Bold JF, Miczek KA (2002) Aggressive behavior as a reinforcer in
mice: activation by allopregnanolone. Psychopharmacology (Berl) 163: 459–
66.
21. Scott JP. Theoretical issues concerning the origin and causes of fighting. In:
EBEaS JP, ed. The physiology of aggression and defeat. New-York: Plenum
Press; 1971, 11–42.
22. Groves JO (2007) Is it time to reassess the BDNF hypothesis of depression? Mol
Psychiatry 12: 1079–1088.
23. Greenberg ME, Xu B, Lu B, Hempstead BL (2009) New insights in the biology
of BDNF synthesis and release: implications in CNS function. J Neurosci 29(41):
12764–12767.
24. Parain K, Murer MG, Yan Q, Faucheux B, Agid Y, et al. (1999) Reduced
expression of brain-derived neurotrophic factor protein in Parkinson’s disease
substantia nigra. Neuroreport 10: 557–561.
25. Yuan Y, Sun J, Zhao M, Hu J, Wang X, et al. (2010) Overexpression of alpha-
synuclein down-regulates BDNF expression. Cell Mol Neurobiol Apr 20. [in
press].
26. Kudryavtseva NN (1991) The sensory contact model for the study of aggressive
and submissive behaviors in male mice. Aggress Behav 17: 285–291.
27. Avgustinovich DF, Kovalenko IL, Bondar NP (2005) Choice of "control" in
experimental researches of animal social interactions in mice. Ross Fiziol Zh
Im I M Sechenova 91(12): 1454–68. Russian.
28. Rosen GD, Williams AG, Capra JA, Connolly MT, Cruz B, et al. (2000) The
Mouse Brain Library @ www.mbl.org. Int. Mouse Genome Conference, 14,
166. www.mbl.org.
29. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid
guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:
156–159.
30. Coccaro EF (1992) Impulsive aggression and central serotonergic system
function in humans: an example of a dementional brain behavior relationship.
Int Clin Psychopharmacol 7: 3–12.
31. Miczek KA, Faccidomo SP, Fish EW, DeBold JF (2007) Neurochemistry and
molecular neurobiology of aggressive behavior In Lajtha A, Blaustein JD, eds.
Handbook of Neurochemistry and Molecular Neurobiology: Behavioral
neurochemistry, neuroendocrinology and molecular neurobiology. Springer-
Verlag, Berlin, Heidelberg. pp 285–336.
32. de Boer SF, Caramaschi D, Natarajan D, Koolhaas JM (2009) The vicious cycle
towards violence: focus on the negative feedback mechanisms of brain serotonin
neurotransmission. Front Behav Neurosci 3: 52.
33. Wersinger C, Sidhu A (2003) Attenuation of dopamine transporter activity by
alpha-synuclein. Neurosci Lett 340: 189–192.
34. Mash DC, Ouyang Q, Pablo J, Basile M, Izenwasser S, et al. (2003) Cocaine
abusers have an overexpression of alpha-synuclein in dopamine neurons.
J Neurosci 23(7): 2564–2571.
35. Kreek MJ (1996) Cocaine, dopamine and the endogenous opioid system. J Addict
Dis 15(4): 73–96.
Snca and Agonistic Behavior
PLoS ONE | www.plosone.org 5 November 2010 | Volume 5 | Issue 11 | e1408936. Mauceli G, Busceti CI, Pellegrini A, Soldani P, Lenzi P, et al. (2006)
Overexpression of alpha-synuclein following methamphetamine: is it good or
bad? Ann NY Acad Sci 1074: 191–197.
37. Nichols CD, Garcia EE, Sanders-Bush E (2003) Dynamic changes in prefrontal
cortex gene expression following lysergic acid diethylamide administration.
Brain Res Mol Brain Res 111: 182–188.
38. Miczek KA, Yap JJ, Covington HE, III (2008) Social stress, therapeutics and
drug abuse: Preclinical models of escalated and depressed intake Pharmacol
Therap 120(2): 102–128.
39. Goloshchapov AV, Filipenko ML, Bondar NP, Kudryavtseva NN (2005)
Decrease of kappa-opioid receptor mRNA level in ventral tegmental area of
male mice after repeated experience of aggression. Brain Res Mol Brain Res
135: 290–292.
40. Spangler R, Ho A, Zhou Y, Maggos CE, Yuferov V, et al. (1996) Regulation of
kappa opioid receptor mRNA in the rat brain by "binge’ pattern cocaine
administration and correlation with preprodynorphin mRNA. Brain Res Mol
Brain Res 38: 71–76.
41. Azaryan AV, Clock BJ, Rosenberger JG, Cox BM (1998) Transient upregulation
of mu opioid receptor mRNA levels in nucleus accumbens during chronic
cocaine administration. Can J Physiol Pharmacol 76: 278–283.
42. Nikulina EM, Hammer RP, Jr., Miczek KA, Kream RM (1999) Social defeat
stress increases expression of mu-opioid receptor mRNA in rat ventral tegmental
area. Neuroreport 10: 3015–3019.
43. Crespo JA, Manzanares J, Oliva JM, Corchero J, Palomo T, et al. (2001)
Extinction of cocaine self-administration produces a differential time-related
regulation of proenkephalin gene expression in rat brain. Neuropsychopharma-
cology 25: 185–194.
44. Kudryavtseva NN, Avgustinovich DF (1998) Behavioral and physiological
markers of experimental depression induced by social conflicts (DISC). Aggress
Behav 24: 271–286.
45. Hahn MK, Blakely RD (2002) Monoamine transporter gene structure and
polymorphisms in relation to psychiatric and other complex disorders.
Pharmacogenomics J 25: 487–495.
46. Heinz A, Mann K, Weinberger DR, Goldman D (2001) Serotonergic
dysfunction, negative mood states, and response to alcohol. Alcohol Clin Exp
Res 25: 487–495.
47. Kudriavtseva NN, Filipenko ML, Bakshtanovskaia IV, Avgustinovich DF,
Alekseenko OV, et al. (2004) Changes in the expression of monoaminergic genes
under the influence of repeated experience of agonistic interactions: from
behavior to gene. Russ J Genetics 40: 590–604.
Snca and Agonistic Behavior
PLoS ONE | www.plosone.org 6 November 2010 | Volume 5 | Issue 11 | e14089